BPC-157 + TB-500 Spray

Research Benefits

• Synergistic Tissue Repair: Combines the gastric-protective and wound-healing properties of BPC-157 with the actin-regulatory and anti-inflammatory effects of TB-500, producing enhanced tissue repair outcomes beyond either peptide alone
• Tendon & Ligament Research: Published studies suggest the combination accelerates collagen organization and tensile strength recovery in connective tissue models
• Musculoskeletal Recovery: Investigated for complementary mechanisms in muscle fiber repair (TB-500) and neuromuscular junction protection (BPC-157)
• Gastrointestinal Protection: BPC-157's well-documented gut cytoprotective effects combined with TB-500's systemic anti-inflammatory action
• Angiogenesis Support: Both peptides independently promote new blood vessel formation through distinct signaling pathways, potentially producing additive vascularization

Mechanism of Action

This combination leverages two complementary repair mechanisms:

BPC-157 Pathway

• Upregulates growth hormone receptor expression in injured tissues
• Modulates the FAK-paxillin pathway for enhanced cell migration to wound sites
• Promotes VEGF-mediated angiogenesis and nitric oxide system activation
• Protects against NSAID-induced GI damage through prostaglandin system modulation

TB-500 Pathway

• Sequesters G-actin monomers, promoting actin polymerization and cellular motility
• Facilitates stem cell migration and differentiation at injury sites
• Downregulates NF-kB-mediated inflammatory cascades
• Promotes laminin and fibronectin expression for extracellular matrix remodeling

The synergy arises from BPC-157 enhancing local tissue receptivity while TB-500 drives systemic cellular repair responses, creating a complementary repair cascade.

Research Protocol

For research purposes only. Not for human consumption.

• Available Configurations: 5mg BPC + 5mg TB or 10mg BPC + 10mg TB per vial
• Typical Research Dose (combined): 250-500 mcg BPC-157 + 250-500 mcg TB-500 per administration in preclinical studies
• Administration: Subcutaneous injection; some protocols use localized injection near the tissue of interest
• Research Cycle: 4-6 week protocols are common in tissue repair studies
• Frequency: Once daily in most published research designs

Reconstitution

• Reconstitute with bacteriostatic water
• Both peptides are co-lyophilized for single-injection convenience
• Store at 2-8 °C after reconstitution; use within 30 days

Safety & Storage

• Lyophilized: Store at -20 °C for long-term stability; 2-8 °C for up to 6 months
• Reconstituted: Refrigerate at 2-8 °C; use within 30 days
• Protect from light and avoid freeze-thaw cycles

Research Considerations

• Both BPC-157 and TB-500 have extensive safety data in preclinical literature with no significant adverse effects reported at research-relevant doses
• BPC-157 is a gastric pentadecapeptide with inherent stability; TB-500 is an actin-binding protein fragment with broad tissue distribution
• Consider potential interactions with anticoagulant compounds due to both peptides' angiogenic properties
• For research use only

Frequently Asked Questions

• Why combine BPC-157 and TB-500?

  Each peptide addresses tissue repair through distinct mechanisms. BPC-157 enhances local growth factor signaling and GI protection, while TB-500 drives systemic cellular migration and anti-inflammatory responses. The combination produces synergistic repair outcomes documented in comparative studies.

• What is the difference between the 5mg and 10mg versions?

  The 5mg+5mg and 10mg+10mg configurations offer different total peptide quantities per vial, allowing researchers to select based on study duration and dosing requirements. The peptide ratios are identical.

• Is there research supporting the combination?

  While most published studies examine each peptide individually, the complementary mechanisms are well-characterized and the combination is widely used in research settings targeting connective tissue, musculoskeletal, and wound healing applications.

• What purity standard is used?

  ≥99% purity for both peptides, verified by HPLC and mass spectrometry. Full COA provided.